Search Results - Schey, Steve

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    The Cost Impact of Lenalidomide for Newly Diagnosed Multiple Myeloma in the EU5

    The Cost Impact of Lenalidomide for Newly Diagnosed Multiple Myeloma in the EU5 by Schey, Steve, Montero, Luis Felipe Casado, Stengel-Tosetti, Chloe, Gibson, Craig J., Dhanasiri, Sujith

    Published 2017
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  2. 2
    Risk of relapse of multiple myeloma following kidney transplantation

    Risk of relapse of multiple myeloma following kidney transplantation by Shah, Sapna, Ibrahim, Maria, Delaney, Michael, Schey, Steve, Bygrave, Ceri, Streetly, Matthew, Benjamin, Reuben

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  3. 3
    GCS-100, a novel galectin-3 antagonist, modulates MCL-1, NOXA, and cell cycle to induce myeloma cell death

    GCS-100, a novel galectin-3 antagonist, modulates MCL-1, NOXA, and cell cycle to induce myeloma cell death by Streetly, Matthew J., Maharaj, Lenushka, Joel, Simon, Schey, Steve A., Gribben, John G., Cotter, Finbarr E.

    Published 2010
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  4. 4
    Longitudinal validity and reliability of the Myeloma Patient Outcome Scale (MyPOS) was established using traditional, generalizability and Rasch psychometric methods

    Longitudinal validity and reliability of the Myeloma Patient Outcome Scale (MyPOS) was established using traditional, generalizability and Rasch psychometric methods by Ramsenthaler, Christina, Gao, Wei, Siegert, Richard J., Schey, Steve A., Edmonds, Poly M., Higginson, Irene J.

    Published 2017
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  5. 5
    The Myeloma Patient Outcome Scale is the first quality of life tool developed for clinical use and validated in patients with follicular lymphoma

    The Myeloma Patient Outcome Scale is the first quality of life tool developed for clinical use and validated in patients with follicular lymphoma by Davies, Joanna M., Osborne, Thomas R., Edmonds, Polly M., Schey, Steve A., Devereux, Steve, Higginson, Irene J., Ramsenthaler, Christina

    Published 2017
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:

Search Tools: